Systematic review and meta-analysis finds no significant association between diabetic retinopathy and age-related macular degeneration
Diabetic retinopathy and age-related macular degeneration show no significant link
This systematic review and meta-analysis evaluates the association between diabetic retinopathy and age-related macular degeneration. The au…
A meta-analysis found no significant relationship between diabetic retinopathy and age-related macular degeneration, though existing data ha…
High LDL-C to HDL-C ratio linked to cardiovascular events in type 2 diabetes with retinopathy
High cholesterol ratio raises heart risk in diabetics
This post hoc analysis of a randomized controlled trial in 5,006 high-risk type 2 diabetes patients with diabetic retinopathy found that a h…
A routine cholesterol test may reveal hidden heart danger in people with diabetes, even when taking cholesterol drugs.
OCT-A metrics show association with diabetic retinopathy status in cross-sectional study
Eye Scan Spots Diabetes Vision Damage Earlier
This cross-sectional study abstract evaluates the association between OCT-A metrics and diabetic retinopathy status in 108 adult eyes. The f…
A fast, painless eye scan can catch diabetes-related vision damage years before symptoms appear, offering a real chance to save sight before…
Meta-analysis finds AI screening tools strongly associated with diabetic retinopathy detection
AI tools show strong link to spotting diabetic eye disease
This meta-analysis of observational and diagnostic studies reports a pooled odds ratio of 5.79 (95% CI: 5.22–6.42) for standalone deep learn…
AI screening tools were linked to better detection of diabetic eye disease in a large review of studies, suggesting they could help identify…
Preclinical deep learning model for diabetic retinopathy screening in low-resource settings
AI Model Spots Diabetic Eye Disease from Smartphone Photos
This preclinical study evaluates an imbalance-aware optimal transport learning approach for diabetic retinopathy detection from smartphone i…
A new AI approach detects diabetic retinopathy from smartphone images with 89% sensitivity, offering hope for low-resource screening.
Meta-analysis links diabetic retinopathy with anxiety and depression in over 383,000 patients.
Diabetes Eye Disease and Depression Feed Each Other — and Doctors Are Just Catching On
This meta-analysis synthesizes observational data from 383,195 patients with diabetic retinopathy and/or diabetes mellitus to evaluate the a…
Diabetic eye disease and depression trap patients in a two-way cycle where each condition significantly raises the risk of the other.
Three-parameter online nomogram predicts diabetic retinopathy risk in community-dwelling type 2 diabetes patients.
Three Numbers Could Tell Your Doctor If Your Eyes Are at Risk
This retrospective cohort study evaluated a three-parameter online nomogram using diabetes duration, HbA1c, and high BMI (≥24 kg/m²) to pred…
A free, web-based calculator using only your diabetes duration, blood sugar control, and BMI could help doctors spot who needs an urgent eye…
Cross-sectional review of diabetic retinopathy prevalence and risk factors in 384 Somaliland patients
Half of Diabetic Patients at This Hospital Had Eye Damage — and Didn't Know It
This observational, descriptive cross-sectional review examines diabetic retinopathy (DR) prevalence and associated risk factors among 384 p…
Half of diabetic patients at a Somaliland hospital had serious eye damage without knowing it, proving regular screenings are vital for preve…
FDA Approves Eylea HD (aflibercept) for nAMD, DME, Diabetic Retinopathy, and Macular Edema Following RVO
FDA approves a new, higher-dose version of the eye medicine Eylea.
The FDA has approved Eylea HD, a VEGF inhibitor, for the treatment of neovascular age-related macular degeneration, diabetic macular edema, …
FDA approves higher-dose Eylea to treat four eye conditions that damage the retina and threaten vision, potentially reducing how often patie…